Amarin Corp ADR (AMRN): Next-Year EPS Estimate 257.14%
As of 2026-06-11, Amarin Corp ADR (AMRN) has a next-year EPS growth estimate of 257.14%.
On 2026-04-30, analyst consensus for AMRN's next-year EPS growth shifted from 140.00% to 257.14% — a positive change of 117.14 percentage points. The revised estimate has been sustained across 31 subsequent trading sessions. Current-year growth is projected at 61.11%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- EPS growth next year
- 257.14%
- EPS growth this year
- 61.11%
- EPS next quarter (est)
- -$0.01
- Last price
- $14.90
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 257.14% | 61.11% | -$0.01 | $14.90 |
| 2026-06-10 | 257.14% | 61.11% | -$0.01 | $14.76 |
| 2026-06-09 | 257.14% | 61.11% | -$0.01 | $14.89 |
| 2026-06-08 | 257.14% | 61.11% | -$0.01 | $14.20 |
| 2026-06-07 | 257.14% | 61.11% | -$0.01 | $13.93 |
| 2026-06-04 | 257.14% | 61.11% | -$0.01 | $13.80 |
| 2026-06-03 | 257.14% | 61.11% | -$0.01 | $14.53 |
| 2026-06-02 | 257.14% | 61.11% | -$0.01 | $14.47 |
| 2026-06-01 | 257.14% | 61.11% | -$0.01 | $14.36 |
| 2026-05-31 | 257.14% | 61.11% | -$0.01 | $14.49 |
| 2026-05-28 | 257.14% | 61.11% | -$0.01 | $14.41 |
| 2026-05-27 | 257.14% | 61.11% | -$0.01 | $14.52 |
| 2026-05-26 | 257.14% | 61.11% | -$0.01 | $14.30 |
| 2026-05-25 | 257.14% | 61.11% | -$0.01 | $14.43 |
| 2026-05-24 | 257.14% | 61.11% | -$0.01 | $14.43 |
| 2026-05-21 | 257.14% | 61.11% | -$0.01 | $14.55 |
| 2026-05-20 | 257.14% | 61.11% | -$0.01 | $14.27 |
| 2026-05-19 | 257.14% | 61.11% | -$0.01 | $14.05 |
| 2026-05-18 | 257.14% | 61.11% | -$0.01 | $14.06 |
| 2026-05-17 | 257.14% | 61.11% | -$0.01 | $14.56 |
| 2026-05-14 | 257.14% | 61.11% | -$0.01 | $14.78 |
| 2026-05-13 | 257.14% | 61.11% | -$0.01 | $15.07 |
| 2026-05-12 | 257.14% | 61.11% | -$0.01 | $14.95 |
| 2026-05-11 | 257.14% | 61.11% | -$0.01 | $15.02 |
| 2026-05-10 | 257.14% | 61.11% | -$0.01 | $15.05 |
| 2026-05-07 | 257.14% | 61.11% | -$0.01 | $14.84 |
| 2026-05-06 | 257.14% | 61.11% | -$0.01 | $14.90 |
| 2026-05-05 | 257.14% | 61.11% | -$0.01 | $14.50 |
| 2026-05-04 | 257.14% | 61.11% | -$0.01 | $14.24 |
| 2026-05-03 | 257.14% | 61.11% | -$0.01 | $14.07 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Amarin Corp ADR's next-year EPS growth estimate?▾
As of 2026-06-11, Amarin Corp ADR (AMRN) has a next-year EPS growth estimate of 257.14%, based on analyst consensus.
When was the latest EPS estimate revision for AMRN?▾
The most recent revision occurred on 2026-04-30, when analysts adjusted the next-year EPS growth estimate from 140.00% to 257.14%.
What sector and industry does Amarin Corp ADR belong to?▾
Amarin Corp ADR operates in the Healthcare sector, specifically the Drug Manufacturers - General industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. AMRN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Amarin Corp ADR (AMRN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports